Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Insights from immuno-oncology:...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: James L Gulley, Julie R Brahmer, Pedro J Romero, Francesco M Marincola, Charles G Drake, Stefani Spranger, Lisa H Butterfield, Douglas G McNeel, Alessandra Cesano, Thomas F Gajewski, Howard L Kaufman, Bernard A Fox, Leisha A Emens, Mario Sznol, Tanja D de Gruijl, Daniel S Chen, Patrick Hwu, Paolo Antonio Ascierto, Walter J Urba, Jon M Wigginton, Robert O Dillman, Michael B Atkins, Kim A Margolin, Paul M Sondel, Michael T Lotze, Ana Carrizosa Anderson, Ernest C Borden, David Kaufman, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, George J Weiner, Jeffrey S Weber, F Stephen Hodi Jr
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Online Access:https://jitc.bmj.com/content/8/1/e000878.full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://jitc.bmj.com/content/8/1/e000878.full

Similar Items

  • Cancer immunotherapy trials: leading a paradigm shift in drug development
    by: Leisha A Emens, et al.
    Published: (2016-06-01)
  • It’s TIME for a biomarker-driven approach to cancer immunotherapy
    by: Leisha A Emens
    Published: (2016-06-01)
  • Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
    by: Francesco Marincola, et al.
    Published: (2020-10-01)
  • Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
    by: James L Gulley, et al.
    Published: (2022-09-01)
  • 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model
    by: Jeffrey Schlom, et al.
    Published: (2023-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs